Abstract: A series of naphthopyran derivatives 3a-f were prepared. Reaction of 2-amino-4-(p-chlorophenyl)-7-methoxy-4H-naphtho[2,1-b]pyran-3-carbonitrile (3b) with Ac 2 O afforded two products, 2-acetylamino-7-methoxy-4-(p-chlorophenyl)-4H-naphtho-[2,1-b]pyran-3-carbonitrile (4) and 10,11-dihydro-3-methoxy-9-methyl-12-(p-chlorophenyl)-12H-naphtho[2,1-b]pyran[2,3-d]pyrimidine-11-one (5) and treatment of 3b with benzoyl chloride gave the pyranopyrimidin-11-one derivative 6. While treatment of 3b with formamide afforded 11-amino-3-methoxy-12
Introduction
Pyran and fused 4H-pyran derivatives have attracted a great deal of interest owing to their antimicrobial activity [1] [2] [3] [4] [5] , inhibition of influenza, virus sialidases [6] , mutagenic activity [7] , activity as antiviral [8] and antiproliferation agents [9] , sex-pheromones [10] , antitumor [11] and anti-inflammatory agents [12] . Moreover, pyran derivatives are well known for their antihistaminic activity [13] . Also pyrimdines are an important class of compounds and have widespread applications from pharmaceuticals to materials [14] , with activities such as Tie-2 kinase inhibitors [15] , HIV-1 inhibitor [16] , anti-malarial [17] , adenosine A1 receptor antagonism [18] , anticancer [19] , analgesic [20] , cardiovascular [21] and antiallergic activities [22] . In view of the important biological properties of the pyran and pyrimidine derivatives as medicinal agents, we report here the synthesis and antimicrobial activities of new naphthopyrano, naphthopyranopyrimidine and naphthopyranotriazolopyrimidine derivatives.
Results and Discussion
Condensation of 6-methoxy-2-naphthol (1) with substituted 4-halobenzylidenmalononitriles 2a-c and/or ethyl 4-halobenzylidenmalonates 2d-f afforded the corresponding 2-amino-4-(p-halophenyl)-7-methoxy-4H-naphtho[2,1-b]pyran-3-carbonitriles 3a-c and ethyl-2-amino-4-(p-halophenyl)-7-methoxy-4H-naphtho[2,1-b]pyran-3-carboxylates 3d-f, respectively [23, 24] (Scheme 1). The structure of compounds 3a-f were established by spectral data. The IR spectrum of compounds 3a-f showed absorptions at 3,466-3,350, 3,346-3,314 cm −1 (NH 2 ), 3,192-3,000 cm −1 (CH-aromatic), Treatment of 3b with Ac 2 O gave two products, depending on the reaction time; one product was identified as 2-acetylamino-7-methoxy-4-(p-chlorophenyl)-4H-naphtho[2,1-b]pyran-3-carbonitrile (4, 1/2 hour), while the other was identified as 10,11-dihydro-3-methoxy-9-methyl-12
Scheme 1. Synthesis of naphthopyran derivatives 3a-f.
pyrimidine-11-one (5, 3 hours). Support for structure 5 was obtained by its independent synthesis by the reaction of 3e with CH 3 CN in the presence of dry HCl gas [25] . Reaction of 3b with benzoyl chloride gave the pyranopyrimidin-11-one derivative 6, while with formamide afforded 11-amino-3-methoxy-12-(p-chlorophenyl)-12H-naphtho [2,1-b] The structure of compounds 4-7 were established from their spectral data. The IR spectrum of compound 4 showed absorptions at 3,400 (NH), 2 Reaction of 3b with triethyl orthoformate gave the corresponding 2-ethoxymetheneamino derivative 8. Hydrazinolysis of 8 in EtOH at room temperature yielded 10-amino-10,11-dihydro-11-imino-3- (9) . During treatment of 8 with phenylhydrazine, an nonisolable addition product A was formed first, followed by elimination of the nonisolable ethyl formatephenylhydrazone to give the enaminonitrile 3b. Ammonolysis of 8 in MeOH at room temperature afforded compound 7 and aminolysis of 8 with methylamine and/or dimethylamine gave the corresponding 10-methyl-pyranopyrimidine and N,N-dimethylaminomethylene derivatives 10 and 11, respectively (Scheme 3).
The structure of compounds 8-11 were established from their spectral data. The IR spectrum of compound 8 showed absorptions at 2,203 cm −1 (C≡N), while compound 9 showed υ at 3,316, 3,270
(NH 2 ), 3,209 cm −1 (NH) and compound 11 showed an absorption at 2,204 cm −1 (C≡N 
EtOH
Reaction of 9 with formic acid or triethyl orthoformate, acetylchloride and benzoyl chloride afforded the corresponding triazolopyrimidine derivatives 12-14, while cyclocondensation of 9 with ethyl cyanoacetate gave the corresponding 2-cyanomethyl derivative 15. Treatment of 9 with ethyl chloroformate in dry benzene afforded traizolo-2-one derivative 16. Reaction of 9 with benzaldehyde gave 10-benzalamino-10,11 (17) instead of the expected triazolopyrimidine derivative 14 (Scheme 4). [26, 27] . Ampicillin and ketoconazole were used as standard drugs for the bacteria and fungi, respectively. Preliminary screening of the naphthopyran derivatives and standard drugs was performed at fixed concentrations of 500 μg/mL. Inhibition was recorded by measuring the diameter of the inhibition zone at the end of 24 hours for bacteria and 72 hours for fungi. Each experiment was repeated twice. Based on the results of zone of inhibition, the minimum inhibitory concentration (MIC) of compounds 3-17 against all bacterial and fungal strains was determined by the liquid dilution method. Stock solutions of the tested compounds with 500, 250, 200, 100, 50, 25, 12.5, and 6.25 μg/mL concentrations were prepared with DMSO as solvent. The solutions of standard drugs, ampicillin and ketoconazole, were prepared in the same concentrations. The minimum inhibitory concentration at which no growth was observed was taken as the MIC value ( Table 1 ). The comparison of the MICs (μg/mL) of potent compounds and standard drugs against tested strains are presented in Table 1 . Investigation of the antibacterial screening data showed that some of the compounds were active against all four pathogenic bacteria. Ethyl 2-amino-4-(p-chlorophenyl)naphthopyrane-3-carboxylate (3e), triazolopyrimidine derivative 12, 2-methyl-triazolopyrimidine derivative 13, 2-phenyl-triazolopyrimidine derivative 14 and, 2-oxatriazolopyrimidine derivative 16 exhibited good activity against S. aureus. Similarly 2-amino-3-cyano-4-(p-flourophenyl)naphthopyran (3c), 2-methyltriazolopyrimidine derivative 14, triazolopyrimidine derivative 12, triazolopyrimidine 2-ethanenitrile derivative 15 and 2-oxa-triazolopyrimidine derivative 16 exhibited good activity against B. cereus and 2-amino-3-cyano4-(p-bromophenyl)naphthopyran (3a), 2-amino-3-cyano-4-(p-chlorophenyl)naphthopyran (3b), 2-amino-3-cyano-4-(p-flourophenyl) naphthopyran 3c, ethyl 2-amino-4-(p-chlorophenyl)naphthopyran-3-carboxylate (3e), 2-methyltriazolopyrimidine derivative 13 and triazolopyrimidine 2-ethanenitrile derivative 16 exhibited good activity against E. coli, while 2-amino-3-cyano-4-(p-bromo/chloro/fluorophenyl)naphthopyran derivatives 3a-c, triazolopyrimidine derivative 12, 2-phenyltriazolopyrimidine derivative 14 and 2-oxatriazolopyrimidine derivative 16 exhibited good activity against S. marcescens. Aminoimino derivative 9 was inactive against S. aureus, while the pyranpyrimidin-11-one 6 and 10-benzalaminopyranopyrimidine derivative 17 was inactive against B. cereus, the compounds ethyl 2-amino-4-(pchlorophenyl)naphthopyrane-3-carboxylate (3e), 11-amino-pyranopyrimidine 7 and 2-ethoxymethyleneamino derivative 8 was inactive against E. coli, and the 2-acetylamino-pyranopyrimidine compound 4 was inactive against S. marcescens. The remaining compounds showed moderate to weak antibacterial activity. The antifungal results (Table 1) revealed that the synthesized compounds showed variable degrees of inhibition against the tested fungi. The compounds 2-amino-3-cyano-4-(p-fluorophenyl)naphthopyran (3c), ethyl 2-amino-4-(p-chlorophenyl)naphthopyran-3-carboxylate (3e), and 2-phenyltriazolopyrimidine 14 possessed good antifungal activity against A. fumigatus and C. albicans, while the compounds 9-methyl-pyranopyrimidine 5, 11-amino-pyranopyrimidine 7, N,N-dimethylaminomethylene derivative 11 and 10-benzalaminopyranopyrimidine 17 were inactive against A. fumigates, and the 2-acetylaminopyranopyrimidine 4 and 10-benzalaminopyranopyrimidine 17 were inactive against C. albicans. The remaining compounds showed moderate to weak antifungal activity.
Experimental

General
Melting points were determined on a Stuart melting point apparatus and are uncorrected. IR spectra (ν, cm ) were recorded in KBr using a FT-IR 5300 spectrometer and aPerkin Elmer spectrum RXIFT-IR system. The 1 H-NMR at (300 MHz) and 13 C-NMR spectra (75 MHz) were recorded in DMSO-d 6 on a
Varian Mercury VX-300 NMR spectrometer. Chemical shifts (δ) are referred to that of the solvent.
Mass spectra were measured on a Shimadzu GMMS-QP-1000 EX mass spectrometer at 70 eV. The elemental analyses were performed at the Micro Analytical Center, Cairo University, Egypt.
General Procedure: Synthesis of 4H-Pyran Derivatives 3a-f
A mixture of substituted 4-halobenzylidenmalononitriles 2a-c (10 mmol) and/or ethyl 4-halobenzylidenmalonates 2d-f (10 mmol), 6-methoxy-2-naphthol (1) (0.17 g, 10 mmol) and piperidine (0.5 mL) in absolute EtOH (50 mL) was heated until precipitation was completed. The precipitate was collected by filtration and recrystallized from dioxane and EtOH/benzene respectively. [2,3-d] pyrimidine-11-one (6) . A solution of 3b (0.36 g, 10 mmol) in benzoyl chloride (20 mL) was heated under reflux for 6 hours. The excess of benzoyl chloride was removed under reduced pressure and the residue was poured into cold water. The precipitate was collected by filtration, washed with CCl 4 (10 mL) to remove the formed benzoic acid and the residue was dried. [2,1-b] pyrano [2,3-d] 
2-Amino-4-(p-bromophenyl)-7-methoxy-4H-naphtho[2,1-b]pyrane-3-carbonnitrile (3a
2-Amino-4-(p-chlorophenyl)-7-methoxy-4H-naphtho[2,1-b]pyrane-3-carbonnitrile (3b
2-Amino-4-(p-flouroophenyl)-7-methoxy-4H-naphtho[2,1-b]pyran-3-carbonitrile (3c
Ethyl 2-amino-4-(p-bromophenyl)-7-methoxy-4H-naphtho[2,1-b]pyran-3-carboxylate (3d
Ethyl 2-amino-4-(p-chlorophenyl)-7-methoxy-4H-naphtho[2,1-b]pyran-3-carboxylate (3e
Synthesis of 2-acetylamino-7-methoxy-4-(p-chlorophenyl)-4H-naphtho[2,1-b]pyran-3-carbonitrile (4).
Synthesis of 10,11-dihydro-3-methoxy-9-methyl-12-(p-chlorophenyl)-12H-naphtho-[2,1-b]pyrano[2,3-d]pyrimidine-11-one (5). Method
Synthesis of 10,11-dihydro-3-methoxy-9-phenyl-12-(p-chlorophenyl)-12H-naphtho[2,1-b]-pyrano
Synthesis of 11-amino-3-methoxy-12-(p-chlorophenyl))-12H-naphtho
General Procedure: Synthesis of Pyranopyrimidine Derivatives 9 and 10
A mixture of 8 (0.41 g, 10 mmol), hydrazine hydrate (5 mL, 99%) or methylamine (10 mmol) in absolute ethanol (50 mL) was stirred for 1 hour at room temperature. The solid obtained was filtered off and recrystallized from dioxane. [2,1-b] pyrano [2,3-d] pyrimidine (9) 
10-Amino-10,11-dihydro-11-imino-3-methoxy-12-(p-chlorophenyl)-12H-naphtho
Antimicrobial Assay
Inoculums of the bacterial and fungal culture were prepared. To a series of tubes containing 1 mL each of naphthopyran compound solution with different concentrations and 0.2 mL of the inoculums was added. A further 3.8 mL of sterile water was added to each of the test tubes. These test tubes were incubated for 24 hours at 37 °C and observed for the presence of turbidity. This method was repeated by changing naphthopyran compounds for the standard drugs ampicillin and ketoconazole for comparison.
Conclusions
Our interest in the synthesis of such compounds was to focus on their study as antimicrobial agents as a part of our program which aimed at the development of new heterocyclic compounds as more potent antimicrobial agents. In this paper we revealed the synthesis of some new naphthopyran, naphthopyranopyrimidine and naphthopyranotriazolopyrimidine derivatives and the antimicrobial evaluation of all the novel compounds. The structures of these compounds were elucidated on the basis of IR, 1 H-NMR, 13 C-NMR and MS data. Evaluation of the new compounds established that 3a-e, 12-14 and 16 showed improved antimicrobial activity.
